Substance (Drug) Abuse Market Summary

• The Substance Abuse Market Size is anticipated to grow with a significant CAGR during the study period (2020-2034).
• The leading Substance Abuse companies developing therapies in the treatment market include - MediciNova, Omeros, KemPharm, InterveXion Therapeutics, and others.

Request for unlocking the Sample Page of the "Substance Abuse Market Insights"

Key Factors Driving the Substance Abuse Market

• Increasing Prevalence of Substance Use Disorders: The rising number of individuals affected by substance use disorders, including dependence on alcohol, opioids, and other illicit drugs, is a major factor driving the growth of the substance abuse market. Factors such as stress, mental health disorders, and social influences have contributed to higher rates of addiction globally, increasing the demand for effective treatment and rehabilitation services.
• Growing Awareness and Government Initiatives: Governments and healthcare organizations across the world are launching awareness campaigns and public health programs to address substance abuse and addiction. Policies aimed at reducing drug misuse, expanding treatment facilities, and improving access to rehabilitation programs are significantly supporting market growth.
• Advancements in Treatment and Therapy Options: Continuous advancements in addiction treatment, including medication-assisted treatment (MAT), behavioral therapies, and digital mental health platforms, are improving recovery outcomes for patients. New medications and innovative therapeutic approaches are helping healthcare providers manage substance dependence more effectively.
• Increasing Focus on Mental Health Care: The growing recognition of the link between mental health disorders and substance abuse has led to a stronger focus on integrated treatment approaches. Healthcare providers are increasingly combining mental health support with addiction treatment, which is driving the demand for comprehensive substance abuse management programs.
• Expansion of Rehabilitation and Treatment Centers: The increasing number of rehabilitation facilities, outpatient treatment centers, and community-based recovery programs is improving access to substance abuse treatment services. This expansion, particularly in developing regions, is helping address the growing burden of addiction and supporting the overall growth of the substance abuse market.

DelveInsight's "Substance Abuse Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Substance Abuse, historical and forecasted epidemiology as well as the Substance Abuse therapeutics market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Substance Abuse market report provides current treatment practices, emerging drugs, Substance Abuse market share of the individual therapies, current and forecasted Substance Abuse market Size from 2020 to 2034 segmented by seven major markets. The Report also covers current Substance Abuse treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Substance Abuse market.

Substance Abuse Disease Understanding

The DelveInsight’s Substance Abuse market report gives a thorough understanding of the Substance Abuse by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis, and treatment.

Substance Abuse Overview

Substance abuse refers to the harmful or excessive use of psychoactive substances such as alcohol, prescription medications, and illicit drugs that can negatively affect an individual’s physical health, mental well-being, and social life. It occurs when a person repeatedly uses substances in a way that leads to dependence, addiction, or significant impairment in daily functioning.

Substance abuse can result in various health complications, including mental health disorders, organ damage, and increased risk of accidents or injuries. Commonly abused substances include alcohol, opioids, cocaine, cannabis, and prescription drugs such as sedatives or pain relievers. The condition is influenced by multiple factors, including genetic predisposition, environmental influences, psychological stress, and social pressures.

Effective management of substance abuse typically involves a combination of medical treatment, behavioral therapy, counseling, and rehabilitation programs aimed at helping individuals overcome addiction and regain control over their lives.

Substance Abuse Diagnosis

Substance abuse diagnosis involves the clinical assessment and evaluation of an individual to determine whether they are experiencing substance use disorder or harmful patterns of substance consumption. Healthcare professionals diagnose substance abuse by reviewing a patient’s medical history, behavioral patterns, substance use habits, and psychological condition to understand the severity of the problem.

Diagnosis typically includes physical examinations, psychological assessments, and laboratory tests such as blood, urine, or saliva screening to detect the presence of drugs or alcohol in the body. In many cases, clinicians also use standardized diagnostic criteria, such as those outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM), to assess symptoms like loss of control over substance use, cravings, tolerance, and withdrawal.

Early and accurate diagnosis is essential for identifying substance use disorders and enabling healthcare providers to develop appropriate treatment plans. It also helps guide interventions such as counseling, behavioral therapy, medication-assisted treatment, and rehabilitation programs to support recovery and improve patient outcomes.

Substance Abuse Treatment

Substance abuse treatment refers to the range of medical and psychological interventions used to help individuals overcome addiction and manage substance use disorders. The primary goal of treatment is to reduce substance dependence, prevent relapse, and support long-term recovery while improving the individual’s physical and mental well-being.

Treatment typically involves a combination of medical detoxification, medication-assisted therapy, behavioral counseling, and rehabilitation programs. Medications may be prescribed to reduce cravings, manage withdrawal symptoms, or block the effects of certain drugs. In addition, behavioral therapies such as cognitive behavioral therapy (CBT), motivational therapy, and group counseling help individuals address the psychological and social factors associated with substance abuse.

Substance abuse treatment can be provided in inpatient rehabilitation centers, outpatient programs, community health facilities, or specialized addiction treatment clinics. Comprehensive treatment approaches that combine medical care, mental health support, and social rehabilitation are considered most effective for achieving sustained recovery.

It covers the details of conventional and current medical therapies available in the Substance Abuse market for the treatment of the condition. It also provides Substance Abuse treatment algorithms and guidelines in the United States, Europe, and Japan.

Substance Abuse Epidemiology 

The Substance Abuse epidemiology section provides insights about the historical and current Substance Abuse patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Substance Abuse market report also provides the diagnosed patient pool and their trends along with assumptions undertaken. 

Substance Abuse Epidemiology Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Substance Abuse epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2020 to 2034.

Country Wise- Substance Abuse Epidemiology

The epidemiology segment also provides the Substance Abuse epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Substance Abuse Epidemiology Segmentation 

• Total Prevalent Cases of Substance (Drug) Abuse
• Substance-Type Specific Cases of Substance (Drug) Abuse
• Age-Specific Cases of Substance (Drug) Abuse
• Gender-Specific Cases of Substance (Drug) Abuse
• Severity-Based Segmentation of Substance (Drug) Abuse

Recent Developments In The Substance Abuse Treatment Landscape:

• In June 2024: The FDA raised concerns about MDMA as a treatment for PTSD, pointing out flaws in studies conducted by Lykos Therapeutics. Issues included study bias, where participants and therapists could identify those receiving MDMA, and significant increases in blood pressure and pulse rates that could lead to cardiovascular events. An advisory panel was set to review these issues while considering the drug's therapeutic potential.
• In April 2024: The FDA faced criticism over its approval of AvertD, a genetic test aimed at assessing opioid addiction risk. Developed by SOLVD Health, the test identified genetic markers associated with opioid use disorder and was intended for use before prescribing opioids. Despite its theoretical promise, concerns were raised about its real-world effectiveness in preventing addiction. 
• In January 2024 (HealthDay News) – The FDA's recent review concluded that marijuana, currently classified as a Schedule I controlled substance, has less potential for abuse than other drugs in this category and should be reclassified to a lower-risk Schedule III category. The review also found some evidence for its medical use. This reassessment initiative began in 2022 following President Biden's directive to review marijuana’s federal scheduling, with HHS Assistant Secretary Adm. Rachel Levine supporting the reclassification to align it with substances like ketamine and Tylenol with codeine.

Substance Abuse Drug Analysis

The drug chapter segment of the Substance Abuse report encloses the detailed analysis of Substance Abuse marketed drugs and late-stage (Phase-III and Phase-II) Substance Abuse pipeline drugs. It also helps to understand the Substance Abuse clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Substance Abuse Marketed Drugs

Substance abuse marketed drugs include medications that are approved and widely used to treat substance use disorders by reducing cravings, managing withdrawal symptoms, or blocking the effects of addictive substances. These drugs are commonly used as part of medication-assisted treatment (MAT), which combines pharmacological therapy with counseling and behavioral interventions to support recovery.

For opioid use disorder, commonly marketed medications include Methadone, Buprenorphine, and Naltrexone, which help reduce cravings and prevent relapse. In the treatment of alcohol dependence, drugs such as Disulfiram, Acamprosate, and Naltrexone are widely prescribed to support abstinence and reduce alcohol consumption.

These marketed therapies play a crucial role in substance abuse treatment by improving treatment outcomes, lowering relapse rates, and supporting long-term recovery when combined with psychological counseling and rehabilitation programs. Continuous research and development efforts are also expanding the range of available therapies to address different types of substance use disorders more effectively.

Substance Abuse Emerging Drugs

Substance Abuse Emerging Drugs refer to investigational therapies currently being studied in clinical or preclinical stages to improve the treatment of substance use disorders. These emerging therapies aim to enhance treatment effectiveness, reduce relapse rates, and provide longer-lasting or targeted interventions compared with existing medications.

• Devextinetug: Devextinetug is a monoclonal antibody being developed to treat methamphetamine-related disorders and overdose. The therapy works by binding to methamphetamine molecules in the bloodstream, preventing them from reaching the brain and reducing toxic effects. It is currently in Phase II clinical trials.
• INDV-1000: INDV-1000 is an investigational GABA_B receptor positive allosteric modulator under development for substance-related disorders. The drug aims to regulate neural pathways involved in addiction and craving, and it is currently in the preclinical stage of development.
• EMB‑001 (Metyrapone/Oxazepam): EMB-001 is a combination therapy being studied for conditions such as cocaine use disorder and smoking addiction. The drug works by modulating stress hormones and neurosteroids that influence drug-seeking behavior, potentially helping reduce cravings and relapse risk.
• Long-acting implants and injectable therapies: New long-acting formulations, including extended-release naltrexone or buprenorphine implants, are being developed to provide medication coverage for several months to a year, improving treatment adherence and reducing relapse during recovery.
• Novel vaccine-based approaches: Researchers are also exploring vaccines targeting drugs such as fentanyl, designed to stimulate the immune system to neutralize the drug before it reaches the brain, potentially preventing overdose and supporting addiction treatment strategies.

Substance Abuse Market Outlook

The Substance Abuse market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Substance Abuse market trends by analyzing the impact of current Substance Abuse therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of Substance Abuse market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Substance Abuse market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Substance Abuse market in 7MM is expected to witness a major change in the study period 2020-2034.

Key Findings

This section includes a glimpse of the Substance Abuse market in 7MM.

The United States Substance Abuse Market Outlook

This section provides the total Substance Abuse market size and market size by therapies in the United States.

EU-5 Countries Substance Abuse Market Outlook

The total Substance Abuse market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Substance Abuse Market Outlook

The total Substance Abuse market size and market size by therapies in Japan is also mentioned.

Substance Abuse Competitive Landscape

The substance abuse competitive landscape is characterized by the presence of pharmaceutical companies, biotechnology firms, and healthcare service providers that focus on developing medications, behavioral therapies, and rehabilitation programs for the treatment of substance use disorders. Key players are investing in research and development to introduce innovative treatment options, including medication-assisted therapies, long-acting formulations, and digital health solutions that support addiction management.

In addition, companies and healthcare organizations are forming strategic partnerships with rehabilitation centers and mental health institutions to expand treatment access and improve patient outcomes. Increasing emphasis on integrated care models, combining pharmacological treatment with counseling and behavioral therapy, is also shaping competition in the substance abuse treatment market.

Key Substance Abuse Companies In The Market Landscape

The Key Substance Abuse companies actively involved in the Substance Abuse treatment landscape include - 

• MediciNova
• Omeros
• KemPharm
• InterveXion Therapeutics, and others

Substance Abuse Drugs Uptake

This section focuses on the rate of uptake of the potential Substance Abuse drugs recently launched in the Substance Abuse market or expected to get launched in the market during the study period 2020-2034. The analysis covers Substance Abuse market uptake by drugs; patient uptake by therapies; and sales of each drug.   

Substance Abuse Drugs Uptake helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs, and allow the comparison of the drugs on the basis of Substance Abuse market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Substance Abuse Clinical Trial Activities

The Substance Abuse pipeline report provides insights into Substance Abuse clinical trials within Phase II, and Phase III stage. It also analyses Substance Abuse companies involved in developing targeted therapeutics.

Substance Abuse Pipeline Development Activities

The Substance Abuse clinical trial analysis report covers the detailed information of collaborations, acquisition, and merger, licensing, patent details, and other information for Substance Abuse emerging therapies.

Substance Abuse Market Reimbursement Scenario

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

Latest KOL- Views on Substance Abuse Market Report

To keep up with current Substance Abuse market trends, we take KOLs and SMEs ' opinion working in the Substance Abuse domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Substance Abuse market trends. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Substance Abuse Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Substance Abuse Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Substance Abuse Market Report

• The report covers the descriptive overview of Substance Abuse, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Substance Abuse epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Substance Abuse is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of the Substance Abuse market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Substance Abuse market

Substance Abuse Market Report Highlights

• In the coming years, the Substance Abuse market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
• The companies and academics are working to assess challenges and seek opportunities that could influence Substance Abuse R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition      
• Several Substance Abuse companies are developing therapies to improve the treatment outlook. The launch of emerging therapies will significantly impact the Substance Abuse market
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Substance Abuse
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Substance Abuse Market Report Insights

• Substance Abuse Patient Population
• Substance Abuse Therapeutic Approaches
• Substance Abuse Pipeline Analysis
• Substance Abuse Market Size and Trends
• Substance Abuse Market Opportunities
• Impact of upcoming Substance Abuse Therapies

Substance Abuse Market Report Key Strengths

• 11 Years Forecast
• 7MM Coverage
• Substance Abuse Epidemiology Segmentation
• Key Cross Competition
• Highly Analyzed Market
• Substance Abuse Drugs Uptake

Substance Abuse Market Report Assessment

• Current Substance Abuse Treatment Practices
• Substance Abuse Unmet Needs
• Substance Abuse Pipeline Product Profiles
• Substance Abuse Market Attractiveness
• Substance Abuse Market Drivers
• Substance Abuse Market Barriers

Key Questions Answered In The Substance Abuse Market Report:

Substance Abuse Market Insights:

• What was the Substance Abuse drug class share (%) distribution in 2020 and how it would look like in 2034?
• What would be the Substance Abuse total market size as well as market size by therapies across the 7MM during the forecast period (2020-2034)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest Substance Abuse market size during the forecast period (2020-2034)?
• At what CAGR, the Substance Abuse market is expected to grow by 7MM during the forecast period (2020-2034)?
• What would be the Substance Abuse market outlook across the 7MM during the forecast period (2020-2034)?
• What would be the Substance Abuse market growth till 2034, and what will be the resultant market Size in the year 2034?
• How would the unmet needs affect the market dynamics and subsequent analysis of the associated trends?

Substance Abuse Epidemiology Insights:

• What are the disease risk, burden, and regional/ethnic differences of the Substance Abuse?
• What are the key factors driving the epidemiology trend for seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What is the historical Substance Abuse patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What would be the forecasted patient pool of Substance Abuse in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• Where will be the growth opportunities in the 7MM with respect to the patient population pertaining to Substance Abuse?
• Out of all 7MM countries, which country would have the highest prevalent population of Substance Abuse during the forecast period (2020-2034)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2020-2034)?

Current Substance Abuse Treatment Scenario, Marketed Drugs and Emerging Therapies:

• What are the current options for the Substance Abuse treatment in addition to the approved therapies?
• What are the current treatment guidelines for the treatment of Substance Abuse in the USA, Europe, and Japan?
• What are the Substance Abuse marketed drugs and their respective MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
• How many companies are developing therapies for the treatment of Substance Abuse?
• How many therapies are in-development by each company for Substance Abuse treatment?
• How many are emerging therapies in mid-stage, and late stage of development for Substance Abuse treatment?
• What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Substance Abuse therapies?
• What are the recent novel therapies, targets, mechanisms of action and technologies being developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for Substance Abuse and their status?
• What are the current challenges faced in drug development?
• What are the key designations that have been granted for the emerging therapies for Substance Abuse?
• What are the global historical and forecasted market of Substance Abuse?

Reasons to buy Substance Abuse Market Forecast Report

• The report will help in developing business strategies by understanding trends shaping and driving the Substance Abuse market
• To understand the future market competition in the Substance Abuse market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Substance Abuse in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
• Identification of strong upcoming Substance Abuse companies in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for Substance Abuse market
• To understand the future market competition in the Substance Abuse market